(Z)-Endoxifen in Girls With MAS-Associated Peripheral Precocious Puberty
Trial details
- Registry ID
- NCT07869732
- Drugs studied
- (Z)-endoxifen
TrialRedline tracks 4 clinical trials sponsored by Atossa Therapeutics, Inc.: 4 Phase 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| (Z)-Endoxifen in Girls With MAS-Associated Peripheral Precocious PubertyNCT07869732 | (Z)-endoxifen | Not yet recruiting | 2028-06Estimated |
| (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast CancerNCT05607004 | (Z)-endoxifen, goserelin | Active not recruiting | 2026-11Estimated |
| Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast DensityNCT05068388 | Z-Endoxifen | Completed | 2024-06-14Actual |
| A Pre-Surgical PK Study of IM and Intraductally Delivered FulvestrantNCT02540330 | Fulvestrant | Terminated | 2020-08-13Actual |
Names as written in the registry records.
NCT05607004 · Atossa Therapeutics, Inc.
Before: Recruiting. After: Active not recruiting.
NCT05068388 · Atossa Therapeutics, Inc.
Before: Estimated. After: Actual.
Before: 28 Aug 2024. After: 14 Jun 2024.
Before: Active not recruiting. After: Completed.